APOTEX INC — Fluticasone Importer Profile
Pharmaceutical Importer · #4 buyer for Fluticasone · $6.4M import value · 182 shipments · CANADA · DGFT Verified
APOTEX INC is the #4 importer of Fluticasone from India with $6.4M in import value and 182 verified shipments. APOTEX INC holds a 3.9% market share in Fluticasone imports based in CANADA. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, APOTEX INC imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC — Fluticasone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Fluticasone to APOTEX INC?
Verified from 182 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $6.4M | 182 | 100.0% |
APOTEX INC sources Fluticasone from 1 verified Indian supplier based on 182 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does APOTEX INC Compare to Nearest Fluticasone Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN IRELAND LTD | NETHERLANDS | $17.4M | 349 | $50.0K |
| 4 | APOTEX INC ★ | CANADA | $7.9M | 182 | $43.2K |
| 2 | MYLAN IRELAND LIMITED | NETHERLANDS | $6.8M | 136 | $50.0K |
| 3 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR | TURKEY | $4.8M | 96 | $50.0K |
APOTEX INC ranks #4 among 664 Fluticasone importers from India. Average shipment value of $43.2K compared to the market average of $83.7K. The closest competitors by value are MYLAN IRELAND LTD and MYLAN IRELAND LIMITED.
Where Does APOTEX INC Import Fluticasone To?
Destination countries from 182 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $6.4M | 182 | 100.0% |
APOTEX INC imports Fluticasone to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $6.4M.
What Fluticasone Formulations Does APOTEX INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-FLUTICASONE HFA 250MCG/MD(WITH POUCH | $1.7M | 53 |
| APO-FLUTICASONE HFA 125MCG/MD(FLUTICASON | $650.0K | 13 |
| APO-FLUTICASONE HFA 125MCG/MD ( FLUTICASONE PROPIONATE INHALATION AEROSOL 125MCG PER METERED DOSE) | $583.4K | 30 |
| APO-FLUTICASONE HFA 250MCG/MD (WITH POUC | $546.1K | 24 |
| APO-FLUTICASONE HFA 250 MCG/MD (WITH POUCH) (FLUTICASONE PROPIONATE INHALATION AEROSOL 250MCG PER METERED DOS | $511.7K | 12 |
| APO-FLUTICASONE HFA 125MCG/MD FLUTICASONE PROPIONATE INHALATION AEROSOL 125MCGPER METERED DOSE | $400.0K | 8 |
| APO FLUTICASONE HFA 125MCG MD FLUTICASONE PROPIONATE INHALATION AEROSOL 125MCG PER METERED DOSE 1X120 MD | $400.0K | 8 |
| APO-FLUTICASONE HFA 125MCG/MD FLUTICAS | $300.0K | 6 |
| APO-FLUTICASONE HFA 125MCG/MD (FLUTICASO | $150.0K | 3 |
| APO-FLUTICASONE HFA 50MCG/MD(WITH POUCH)(FLUTICASONE PROPIONATE INHALATION AEROSOL / 50 MCG PER METERED)(PS:1X120MD) | $148.6K | 3 |
APOTEX INC imports 22 distinct Fluticasone formulations from India. The top formulation is APO-FLUTICASONE HFA 250MCG/MD(WITH POUCH with 53 shipments worth $1.7M.
Regulatory Requirements: Importing Fluticasone into Canada
What APOTEX INC and other importers must comply with to import Fluticasone from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Fluticasone
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Fluticasone from India and How Much Does APOTEX INC Import?
India exported $55.6M worth of Fluticasone through 9,009 shipments from 239 suppliers to 123 countries, serving 664 buyers globally. APOTEX INC imports $6.4M of this total, accounting for 3.9% of India's Fluticasone exports with 182 shipments from CANADA. This is verified from 182 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for APOTEX INC's Fluticasone Imports?
APOTEX INC's average Fluticasone order value is $35.0K per consignment, based on 182 shipments totaling $6.4M. APOTEX INC is based in CANADA and ranks #4 among all Fluticasone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Fluticasone to APOTEX INC?
APOTEX INC sources Fluticasone from 1 verified Indian supplier: CIPLA LIMITED ($6.4M, 100.0%). This is based on 182 customs records.
How Does APOTEX INC Compare to Other Fluticasone Importers?
APOTEX INC ranks #4 among 664 Fluticasone importers from India with a 3.9% market share. The top 3 importers are MYLAN IRELAND LTD ($17.4M), APOTEX INC ($7.9M), MYLAN IRELAND LIMITED ($6.8M). APOTEX INC processed 182 shipments from CANADA.
About APOTEX INC
APOTEX INC imports 14 products worth $40.9M. Beyond Fluticasone, top products include Apixaban, Atorvastatin, Amino, Acetaminophen, Ramipril. View the complete APOTEX INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluticasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluticasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC's capped import value divided by total capped export value for Fluticasone across all Indian exporters.
- 5.Verified Records: This page is backed by 182 individual customs records matching APOTEX INC importing Fluticasone, covering 22 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 664+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluticasone Import Data for APOTEX INC
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC's Fluticasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC × Fluticasone
Verified from customs records
Company Overview
Top Products by APOTEX INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluticasone. For current order-level data, contact TransData Nexus.